141 related articles for article (PubMed ID: 15650944)
1. M-40403 Metaphore Pharmaceuticals.
Di Napoli M; Papa F
IDrugs; 2005 Jan; 8(1):67-76. PubMed ID: 15650944
[TBL] [Abstract][Full Text] [Related]
2. CC-5013 (Celgene).
Mitsiades CS; Mitsiades N
Curr Opin Investig Drugs; 2004 Jun; 5(6):635-47. PubMed ID: 15242253
[TBL] [Abstract][Full Text] [Related]
3. 109881 Aventis.
Ojima I; Geney R
Curr Opin Investig Drugs; 2003 Jun; 4(6):737-40. PubMed ID: 12901234
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A2A agonists in development for the treatment of inflammation.
Lappas CM; Sullivan GW; Linden J
Expert Opin Investig Drugs; 2005 Jul; 14(7):797-806. PubMed ID: 16022569
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight compounds with transition metals as free radical scavengers and novel therapeutic agents.
Bencini A; Failli P; Valtancoli B; Bani D
Cardiovasc Hematol Agents Med Chem; 2010 Jul; 8(3):128-46. PubMed ID: 20438441
[TBL] [Abstract][Full Text] [Related]
6. Lerisetron. FAES.
Huckle R
Curr Opin Investig Drugs; 2003 Jul; 4(7):874-7. PubMed ID: 14619411
[TBL] [Abstract][Full Text] [Related]
7. Lapatinib ditosylate GlaxoSmithKline.
Kim TE; Murren JR
IDrugs; 2003 Sep; 6(9):886-93. PubMed ID: 12964069
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and analgesic and anti-inflammatory activities 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(p-substituted/nonsubstituted benzal)hydrazone derivatives.
Gökçe M; Utku S; Küpeli E
Eur J Med Chem; 2009 Sep; 44(9):3760-4. PubMed ID: 19535179
[TBL] [Abstract][Full Text] [Related]
9. CKD-602. Chong Kun Dang.
Crul M
Curr Opin Investig Drugs; 2003 Dec; 4(12):1455-9. PubMed ID: 14763132
[TBL] [Abstract][Full Text] [Related]
10. Ganstigmine. Chiesi.
Johnson A
Curr Opin Investig Drugs; 2003 Jul; 4(7):868-73. PubMed ID: 14619410
[TBL] [Abstract][Full Text] [Related]
11. Osmium tetroxide, used in the treatment of arthritic joints, is a fast mimic of superoxide dismutase.
Goldstein S; Czapski G; Heller A
Free Radic Biol Med; 2005 Apr; 38(7):839-45. PubMed ID: 15749379
[TBL] [Abstract][Full Text] [Related]
12. GSK3 inhibitors: development and therapeutic potential.
Cohen P; Goedert M
Nat Rev Drug Discov; 2004 Jun; 3(6):479-87. PubMed ID: 15173837
[No Abstract] [Full Text] [Related]
13. Therapies targeting pain.
Jahnke U; McGee V
IDrugs; 2008 Jan; 11(1):13-5. PubMed ID: 18175253
[No Abstract] [Full Text] [Related]
14. CMT-3. CollaGenex.
Fingleton B
Curr Opin Investig Drugs; 2003 Dec; 4(12):1460-7. PubMed ID: 14763133
[TBL] [Abstract][Full Text] [Related]
15. Nemifitide. Innapharma.
Dingemanse J
Curr Opin Investig Drugs; 2003 Jul; 4(7):859-62. PubMed ID: 14619408
[TBL] [Abstract][Full Text] [Related]
16. MEN-10755. Menarini.
Jones K
Curr Opin Investig Drugs; 2003 Dec; 4(12):1473-8. PubMed ID: 14763135
[TBL] [Abstract][Full Text] [Related]
17. ONO-2506. Ono.
de Paulis T
Curr Opin Investig Drugs; 2003 Jul; 4(7):863-7. PubMed ID: 14619409
[TBL] [Abstract][Full Text] [Related]
18. Noordwijkerhout-Camerino--15th Symposium. Trends in drug research.
Triggle DJ
IDrugs; 2005 Jul; 8(7):563-6. PubMed ID: 15973564
[No Abstract] [Full Text] [Related]
19. Society for Neuroscience - 39th Annual Meeting. Part 1 - Novel therapies for the treatment of CNS disorders and pain.
Al-Shamahi A; Kirkham K; Hookes L
IDrugs; 2009 Dec; 12(12):731-3. PubMed ID: 19943210
[TBL] [Abstract][Full Text] [Related]
20. ZD-6126 AstraZeneca.
Soltau J; Drevs J
IDrugs; 2004 Apr; 7(4):380-7. PubMed ID: 15057644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
